All lobbying filings

TIBER CREEK GROUP

Lobbying for ACADIA PHARMACEUTICALS, INC. · Biopharmaceutical company.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $80,000.00 income · posted Oct 19, 2025

Official filing document

Bills named in this filing 2

HR 1262
Mikaela Naylon Give Kids a Chance Act
S 932
Give Kids a Chance Act of 2025

Lobbying activity 2

Health Issues

Issues related to rare disease treatments, including rare disease research incentives; Issues related to H.R. 1262/S. 932 - Give Kids a Chance Act; Issues related to Medicaid changes in the One Big Beautiful Bill Act (PL 119-21); Issues related to drug pricing reforms.

Taxation/Internal Revenue Code

Issues related to the orphan drug tax credit.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.